CVS Health's total assets reached USD 235,495 mil at the end of 2Q2020, up 7.58% compared to the previous year.
Current assets amounted to USD 62,506 mil, or 26.5% of total assets while cash stood at USD 17,465 mil at the end of 2Q2020.
By contrast, total debt reached USD 92,051 mil at the year-end, or 39.1% of total assets, while the firm's equity amounted to USD 68,355 mil. As a result, net debt stood at USD 74,586 mil at the end of 2Q2020 and accounted for 109% of equity.
Net debt against equity is up 77.5 pp from five years ago (31.6%). The ratio against EBITDA increased from 1.08x seen in 2Q2015 to 3.77x.
The company’s cost of funding amounted to 3.32% in 2Q2020, down 0.601 pp compared to the average over the last 5 years.
You can see all the company’s data at CVS Health profile, or you can download a report on the company in the report section.
Helgi Library 
